Medline Stock Forecast

Stock Price Forecast

According to 27 analysts polled by S&P Global, Medline stock has a consensus rating of "Buy" and an average price target of $45.35. The average 1-year stock price forecast is 7.57% higher than the current stock price, while the lowest is $34 (-19.35%) and the highest is $55 (+30.46%).

Price Target: $45.35 (+7.57%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$34	$45.35	$46	$55
Change	-19.35%	+7.57%	+9.11%	+30.46%

Analyst Ratings

The average analyst rating for Medline stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	17	16	16	16	16	16
Buy	7	7	7	7	7	6
Hold	4	4	4	4	4	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	28	27	27	27	27	27

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ryan Halsted RBC Capital	RBC Capital	Buy Reiterates $46	Buy	Reiterates	$46	+9.11%	Nov 11, 2026
Andrew Obin Bank of America Securities	Bank of America Securities	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Nov 9, 2026
Michael Cherny Leerink Partners	Leerink Partners	Buy Reiterates $43 → $46	Buy	Reiterates	$43 → $46	+9.11%	Nov 5, 2026
Kevin Caliendo UBS	UBS	Buy Reiterates $43 → $49	Buy	Reiterates	$43 → $49	+16.22%	Nov 5, 2026
Erin Wright Morgan Stanley	Morgan Stanley	Buy Reiterates $48	Buy	Reiterates	$48	+13.85%	Nov 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

31.40B

from 28.43B

10.44%

from 28.43B

Revenue Next Year

33.93B

from 31.40B

8.07%

from 31.40B

EPS This Year

1.56

from 1.32

18.43%

from 1.32

EPS Next Year

1.55

from 1.56

-1.07%

from 1.56

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	21.45B	23.23B	25.51B	28.43B	31.40B
Revenue Growth	-	8.31%	9.80%	11.47%	10.44%
Gross Profit	5.22B	5.89B	6.98B	7.52B	8.15B
Gross Margin	24.32%	25.33%	27.35%	26.44%	25.94%
Operating Income	861.00M	1.41B	2.15B	2.18B	3.17B
Net Income	-25.00M	234.00M	1.20B	1.16B	990.42M
EPS	-	-	-	1.32	1.56
EPS Growth	-	-	-	-	18.43%
Forward PE	-	-	-	-	26.97
Free Cash Flow	-	-	-	1.30B	1.61B
No. Analysts	-	-	-	-	24

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	31.6B
Avg	31.4B
Low	31.3B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	11.0%
Avg	10.4%
Low	10.2%

EPS Forecast

Chart

EPS	2026	2027	2028
High	1.70
Avg	1.56
Low	1.40

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	28.8%
Avg	18.4%
Low	6.3%